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Abstract
Background: In this study we evaluated the RespoCheck Mycoplasma triplex real-time PCR for the detection in
bronchoalveolar lavage fluid (BALF) of Mycoplasma (M.) dispar, M. bovis and M. bovirhinis, all three associated with
bovine respiratory disease (BRD). Primers and probes of the RespoCheck Mycoplasma triplex real-time PCR are based
on the V3/V4 region of the 16S rRNA gene of the three Mycoplasma species.
Results: The analytical sensitivity of the RespoCheck triplex real-time PCR was, as determined by spiking experiments
of the Mycoplasma strains in Phosphate Buffered Saline, 300 colony forming units (cfu)/mL for M. dispar, and 30 cfu/mL
for M. bovis or M. bovirhinis. The analytical sensitivity of the RespoCheck Mycoplasma triplex real-time PCRwas, as
determined on purified DNA, 10 fg DNA per assay for M. dispar and 100 fg fo rM. bovis and M. bovirhinis. The analytical
specificity of the RespoCheck Mycoplasma triplex real-time PCR was, as determined by testing Mycoplasmas strains
(n = 17) and other bacterial strains (n = 107), 100, 98.2 and 99.1% for M. bovis, M. dispar and M. bovirhinis respectively.
The RespoCheck Mycoplasma triplex real-time PCR was compared with the PCR/DGGE analysis for M. bovis, M. dispar
and M. bovirhinis respectively by testing 44 BALF samples from calves.
Conclusion: In conclusion, the RespoCheck PCR assay can be a valuable tool for timely and accurate detection of three
Mycoplasma species associated with in bovine respiratory disease.
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Background
Bovine respiratory disease complex (BRDC) is a global
problem causing severe economic losses to the cattle
farming industry through mortality, loss of production,
and treatment costs [1, 2]. It has a complex etiology that
involves various pathogens, host factors, and environ-
mental factors. Viruses such as bovine herpes 1 virus
(BoHV-1, parainfluenza virus 3 (PBIV-3), bovine respira-
tory syncytial Virus (BRSV), respiratory bovine corona-
virus (BoCoV) and bovine viral diarrhoea virus (BVDV)
in conjunction with stress factors have been implicated
as causes of respiratory tract infections of cattle by
immunosuppression and damage to the respiratory epi-
thelium [3]. A primary viral infection can be followed by
an opportunistic secondary infection with bacteria like
Mannheimia haemolytica, Pasteurella multocida, Histo-
philus somni, or Trueperella pyogenes [2, 4, 5], but these
bacteria could also act as primary pathogen. In addition
it has become increasingly clear that Mycoplasmas are
important contributors to BRD, either as primary patho-
gens or in co-infection [2, 6–9]. M. bovis is the best
known Mycoplasma species causing respiratory disease
[4, 7], but also M. dispar and M. bovirhinis have been
associated with BRD [2, 9–11]. M. bovis has not only
been identified as a primary or opportunistic pathogen
in BRD in beef cattle worldwide, but it has also been im-
plicated in other clinical manifestations in cattle, such as
mastitis, otitis, arthritis, and reproductive disorders [7].
M. bovirhinis and M. dispar are regularly isolated from
the nasal cavity of cattle with respiratory disease and are
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usually regarded as an opportunistic pathogen in respira-
tory diseases [7, 12].
Bacteriological, serological and histopathological ex-
aminations are important tools to detect particular
animal-carriers of Mycoplasma [13], however, these
assays are time-consuming, insensitive and can give false
positive results. Bronchoalveolar lavage fluid (BALF)
from calves with BRD may contain various potential
pathogens, but additional antibiotic use in the affected
herds can inhibit cultivation and thereby can cause false-
negative test results. In BRD, differential diagnosis of
these pathogens with rapid turnaround time procedure
is essential to implement appropriate treatment and
intervention measures in a timely manner. Rapid detec-
tion of these pathogens at the early stage of outbreak
can contribute substantially to minimize the spread of
infection and increase treatment efficiency. Today quick,
highly sensitive and species-specific PCRs are used in
the diagnosis of Mycoplasma-associated diseases for M.
dispar [14, 15], M. bovis [4, 16] and M. bovirhinis [17] in
BALF or nasal swabs. Combining a 16S Ribosomal DNA
PCR with denaturing gradient gel electrophoresis
fingerprinting (PCR/DGGE) enabled the simultaneous
detection of mixed Mycoplasma populations, however
information about the detection limit in clinical samples
is limited [18]. Additionally, a DNA microarray assay
was developed for the parallel detection of 37 Myco-
plasma species [19], in which species-specific probes de-
rived from the 23S rRNA and tuf genes were used for
species differentiation.
Multiplex real-time PCR could be a promising and
practical approach to speed up the differential diagnosis
from 1 to 2 weeks for traditional culture to 24 h, with
limited expenses. This will make diagnostic testing more
accessible for veterinary practitioners and thereby
improve BRD diagnosis. This report describes the
RespoCheck triplex PCR developed by Central Veterin-
ary Institute (CVI, Lelystad, The Netherlands) for
detection of three Mycoplasma species.
Methods
Strains and growth conditions
M. bovis (ATCC 25025) and M. bovirhinis (ATCC
5189985) were purchased from the ATCC (United
Kingdom (U.K.), Guernsey, Ireland, Jersey and
Liechtenstein) and cultured in Heart Infusion Broth
Medium (Difco, Detroit, Mich.). All isolates were grown at
37 °C and 5% CO2 for seven days in a modified standard
mycoplasma broth medium [20] containing 19 g of Heart
Infusion Broth, 50 mL of liquid yeast extract (10% [vol/vol];
Oxoid, London, United Kingdom), 2 × 106 U of penicillin
G (Hoechst, Frankfurt, Germany), and 200 mL of heat-
inactivated (56 °C, 30 min) horse serum per liter. Stocks of
each isolate were prepared by freezing 1 mL portions of a
10 mL logarithmic-phase broth culture with 15% gly-
cerol at −80 °C. Cultures were titrated on Heart Infu-
sion Agar and were shown to contain 7 × 106 cfu/mL
for M. bovis and 4 × 105 cfu/mL for M. bovirhinis.
M. dispar NCTC 10125) was provided by Helena
Windsor (Mycoplasma Experience LTD, Bletchingley,
UK) with a titre of 1.6 × 107 cfu/mL. In addition,
DNA from 14 Mycoplasma strains (Table 1) were
provided by Prof. Konrad Sachse (Friedrich-Loeffler-
Institut, Federal Research Institute for Animal Health,
Bundesforschungsinstitut für Tiergesundheit, Jena,
Germany).
Hundred and seven bacterial isolates, representing 39
different species, were used to evaluate of specificity of
the RespoCheck Mycoplasma triplex real-time PCR
assay (Table 2). These included isolates associated with
BRD and isolates associated with other bovine diseases.
Prior to testing by PCR, the identity of the isolates was
confirmed using MALDI-TOF mass spectrometry (MS
Bruker MALDI Biotyper Microflex, version 3.1 with the
reference database version 3.1.66 Bruker Daltonics
GmbH, Germany).
Field samples and isolation of DNA
Calves (n = 44) with or without BRD (increased respira-
tory rate and/or dyspnoea) were sampled for diagnostic
purposes. Sampling of the calves was granted an exemp-
tion from requiring ethics approval by the institutional
Animal Experiment Commission “Dier Experimenten
Commissie (DEC) Lelystad (2013111.b)” because
sampling was performed for diagnostic purposes. BAL
samples were obtained as described [21]. Approximately
35–75 ml BAL was obtained from each calf after instilla-
tion of 100 ml PBS with 10% Fetal Calf serum (FCS).
Foam, large purulent exudates and blood clots were re-
moved from the BALF samples under aseptic conditions.
BALF (25 mL) was centrifuged (4600×g, 10 min, 4 °C).
Sediment was resuspended in 0.5 mL Dulbecco’s min-
imal essential medium (DMEM) with 5% FCS, carefully
added to 1 mL freeze medium (DMEM, 50% FCS and
20% DMSO) and frozen at −80 °C. The BALF superna-
tants were also stored at −80 °C.
For testing the influence of centrifugation of BALF
samples (4600×g, 10 min, 4 °C) on the PCR results we
tested three variants of BALF samples: without centrifu-
gation, supernatant and pellet obtained after centrifuga-
tion (50 times concentrated). DNA was extracted from
200 μL aliquots of BALF samples. We used the MagNA
Pure LC Total Nucleic Acid Isolation Kit (Roche
Applied Science), with the Total NA External_lysis”
protocol (Version 2.11). With the MagNA Pure LC
Total Nucleic Acid Isolation Kit) 32 samples can proc-
essed per run. In all runs a positive control (a mix of
1.4 × 106 cfu/mL M. bovis, 0.5 × 107 cfu/mL M dispar
Cornelissen et al. BMC Veterinary Research  (2017) 13:97 Page 2 of 12
and 1.3 × 105 cfu/mL M. bovirhinis) and a negative
water control (NTC) was included.
RespoCheck primers and probes
To enable testing of testing for BRD associated patho-
gens in a routine setting, real-time PCRs for detection of
viral, bacterial and mycoplasma pathogens in bronchoal-
veolar lavage fluid (BALF) of calves have been set up by
the Central Veterinary Institute (Lelystad, The
Netherlands) under the name RespoCheck. Primers and
probes specific for the bacterial 16S, V3 and V4 regions
were based on the Full length, bacterial 16S sequences
(50,000 in July 2012) were used from the nuccore data-
base at the National Center for Biotechnology Informa-
tion (NCBI, USA, http://www.ncbi.nlm.nih.gov/nuccore).
For M. bovirhinis and M. dispar the nearly full length
16S sequences were used. These sequences and their
taxonomic information were used to build an Insignia-
based database [22] from which pathogen-specific se-
quence regions were extracted with special interest for
the V3 and V4 region because these sequences are often
targeted for metagenomic next-generation sequencing
(NGS) [23]. Using the identified regions, primers and
probes were designed with AlleleID 7.8. (Premier Bio-
soft, palo Alto, USA). The resulting triplex PCR was des-
ignated RespoCheck Mycoplasma triplex real-time PCR
The specificity of the Mycoplasma primers and probes
was also verified against V3-V4 partial sequences of M.
flocculare, M. ovipneumonia and M. hyopneumonia.
RespoCheck triplex and single real-time PCR
The QuantiFast triplex Kit Real Time-PCR kit (Qiagen)
was used for the RespoCheck Mycoplasma triplex real-
time PCR. The assays were conducted in a 20 μl reaction
mix containing 5 μl of the nucleic acid sample, 250 nM of
each primer, 100 nM of each MGB probe, 1× QuantiFast
triplex Real Time-PCR Master Mix and sterile deionised
water. All reactions were conducted with an ABI-7500
with the following cycling parameters: 95 °C for 15 min,
followed by 40 cycles of 94 °C for 15 s and 60 °C for 60 s.
The machine was set to acquire fluorescence on the FAM,
VIC, and NED channels for respectively M. bovis, M.
dispar and M. bovirhinis All primers and probes were
obtained from Life Technologies Europe BV (Bleiswijk,
the Netherlands). The final results were analysed using
ABI-7500 software (Version 1.4). Samples with a Ct of
40 cycles or less were considered to be positive.
Evaluation of the analytical sensitivity and the analytical
specificity
The analytical sensitivity of the RespoCheck triplex PCR
was defined as the ability to detect the lowest concentra-
tion of M. bovis, M. dispar and M. bovirhinis expressed
as a concentration (cfu/mL) [24]. The analytical
Table 1 Mycoplasma strains (n = 17), which were used as reference material
Species (Type strain) ID Ct-values
M. bovis M. dispar M. bovirhinis
M. agalactiae (PG2) R 41b 20.9 - -
M. alkalescens PG 31/D 12 R 18b - 35.7a -
M. bovis PG45 R 9b 19.4 - -
M. bovirhinis PG43 R 12b - - 25.8
M. bovigenitalium PG11 R 8b - - -
M. californicum ST-6 R 26b - - -
M. canadense 275C R 22b - - -
M. canis, PG14 R 74b - - 20.0a
M. dispar 462/2. R 11b - 18.7 -
M. leachii PG50
(former M. bovine group VII)
R 23b - - -
M. mycoides subsp. Mycoides PG1
(former Small Colony Type)
R 84b - - -
Acholeplasma axanthum S743 R 17b - 33.1a -
A. laidlawii PG8 R 10b - - -
A. oculi 19-L R 62b - - -
M. bovis ATCC 25025 23.9 - -
M. dispar (NCTC 10125) ATCC 27140 - 20.3 -
M. bovirhinis ATCC 5189985 - - 20.9
aCross-reactions in the RespoCheck triplex Mycoplasma PCR
bID Friedrich-Loeffler-Institut
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Table 2 Bacterial strains (n = 107), that were used as reference material
Identification (number of isolates tested) CCUG identificationc Source
Acidovorax spp. (3) NAc CVI collectiona
Actinomyces NA CVI collectiona
Aerococcus viridans NA CVI collectionb
Bibersteinia trehalosi Pasteurella trehalosi CCUG 37711
Biberstenia trehalosi 20 AA III 3 E3 NA CVI collectiona
Biberstenia trehalosi 21 AA III 3 E4 NA CVI collectiona
Brucella abortus NA CVI collectionb
Comamonas kerstersii NA CVI collectiona
Corynebacterium bovis (2) NA CVI collectionb
Corynebacterium pseudotuberculosis NA CVI collectionb
Escherichia coli NA CVI collectionb
Gallibacterium anatis (5) NA CVI collectiona
Hafnia alvei NA CVI collectiona
Histophilus somni NA ATCC 22132e
Histophilus somni (4) NA CVI collectiona
Klebsiella oxytoca NA CVI collectionb
Klebsiella pneumoniae NA CVI collectionb
Lactobacillus mucosae NA CVI collectiona
Lactococcus garvieae NA CVI collectionb
Lactococcus lactis NA CVI collectionb
Listeria monocytogenes NA CVI collectionb
Mannheimia heamolytica NA ATCC 14003
Mannheimia heamolytica NA CVI collectiona
Mannheimia haemolytica Mannheimia glucosida CCUG 38457-T
Mannheimia granulomatis Mannheimia granulomatis CCUG 45422-T
Mannheimia granulomatis 25 AA III 3 E8 NA CVI collectiona
Mannheimia haemolytica Mannheimia ruminalis CCUG 38470-T
Mannheimia haemolytica (5) NA CVI collectiona
Mannheimia haemolytica 3 AA III 2 H2 NA CVI collectiona
Mannheimia varigena Mannheimia varigena CCUG 38462-T
Mannheimia varigena 19 AA III 3 E2 NA CVI collectiona
Mannheimia varigena 24 AA III 3 E7 NA CVI collectiona
Micrococcus luteus NA CVI collectionb
Moraxella bovis NA CVI collectionb
Moraxelle lacunata (2) NA CVI collectiona
Mycobacterium avium subsp. paratuberculosis NA CVI collectionb
Mycobacterium bovis NA CVI collectionb
Mycobacterium tuberculosis NA CVI collectionb
Neisseria zoodegmatis NA CVI collectiona
Pantoea agglomerans Erwina herbicola (n = 13) NA CVI collectiona
Pasteurella multocida NA ATCC 15743e
Pasteurella multocida NA CVI collectiona
Pasteurella multocida Bisgaard Taxon 13 CCUG 16497d
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sensitivity of the single and triplex PCRs for M. bovis,
M. dispar and M. bovirhinis was determined with DNA
isolated from 200 μL culture (M. bovis, M. dispar and
M. bovirhinis strain) in a volume of 200 μL elution buf-
fer at a final DNA concentration of 10 ng/ μL. This
DNA preparation was tested in seven 10-fold serial dilu-
tions (5 μL per assay) in PBS, resulting in a range with
10 ng down to 1 fg Mycoplasma DNA per assay. The Ct
was determined for each sample by single and Respo-
Check triplex real-time PCR with a threshold of 50% of
the Delta Rn value (log). The threshold was manually set
at 0.04 in the linear phase of the amplification plot,
whereby the Slope and Correlation Coefficient values
were 3.22 and 99.99% respectively.
The analytical sensitivity of the M. bovis, M. dispar and
M. bovirhinis single and RespoCheck triplex real-time
PCR, was also determined by testing a mixture of M. bovis
(3 × 106 cfu/mL), M. dispar (3 × 106 cfu/mL) and M.
bovirhinis (3 × 105 cfu/mL) in seven 10-fold serial
dilutions in BALF of specific pathogen free (SPF) calves of
3–4 weeks old. Dilution resulted in a series of M. bovis, M.
dispar and M. bovirhinis spiked BALF samples, ranging
from 3 × 106 cfu/mL down to 0.3 cfu/mL. Total DNA was
isolated from each 200 μl sample with the MAGNA pure
isolation kit and the Ct was determined for each sample
(5 μl) by both the single and RespoCheck triplex PCR
assays. The slope of the curve, the efficiency and the detec-
tion limit (for DNA ng/μl; for cells cfu/mL) for each PCR
was determined. To determine the analytical specificity of
the designed RespoCheck triplex PCR, 17 Mycoplasma
isolates and 107 bacterial strains (Table 2) were tested.
Diagnostic sensitivity and specificity in BALF samples
from calves.
For determining the diagnostic specificity, BALF samples
were analysed with the PCR/DGGE method by the
Table 2 Bacterial strains (n = 107), that were used as reference material (Continued)
Pasteurella multocida Bisgaard Taxon 13 CCUG 16498d
Pasteurella multocida Pasteurella multocida ss gallicida CCUG 17978-Td
Pasteurella multocida Pasteurella multocida ss septica CCUG 17977-Td
Not typable Pasteurella aerogenes CCUG 27905d
Proteus mirabillis NA CVI collectiona
Pseudomonas aeruginosa NA CVI collectionb
Psychrobacter spp. NA CVI collectiona
Salmonella enteritica ssp. enteritica serovar Dublin NA CVI collectionb
Salmonella enteritica ssp. enteritica serovar Typhinurium NA CVI collectionb
Serratia marcescans NA CVI collectionb
Staphylococcus aureus NA CVI collectionb
Staphylococcus epidermidis NA CVI collectionb
Streptococcus agalactiae NA CVI collectionb
Streptococcus bovis (5) NA CVI collectiona
Streptococcus dysgalactiae NA CVI collectionb
Streptococcus faecalis NA CVI collectionb
Streptococcus hyointestinalis NA CVI collectiona
Streptococcus pluranimalium (5) NA CVI collectiona
Streptococcus pneumoniae NA CVI collectionb
Streptococcus spp. (3) NA CVI collectiona
Streptococcus uberis NA CVI collectionb
Trueperella pyogenes NA ATCC 9731e
Trueperella pyogenes (5) NA CVI collectiona
Yersinia enterolytica NA CVI collectionb
Yersinia pseudotuberculosis Pasteurella lymphangitidis CCUG 27188-Td
aIsolated from lungs of calves
bIsolated from other tissues of cattle as lungs
cNot applicable
dCCUG: Culture Collection University of Götenborg, Sweden
eATCC: American Type Culture Collection, USA
All bacterial strains, except the CCUG strains, were from an in-house strain collection
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Animal and Plant Health Agency (APHA, Mycoplasma
Team, Addlestone Surrey, UK) as earlier described [18,
25]. To determine the analytical sensitivity of the PCR/
DGGE analysis, four 10-fold serial dilutions of M. bovis
(7 × 104 cfu/mL), M. dispar (16 × 104 cfu/mL), and M.
bovirhinis (0.5 × 104 cfu/mL), were prepared in PBS.
Samples were sent to the APHA and analysed using the
PCR/DGGE method.
Sequencing amplicons
16S rDNA PCR-sequencing was used for confirmation
of the results of RespoCheck Mycoplasma triplex real-
time PCR. 16S rDNA of the DGGE positive /PCR
positive (n = 5) and DGGE negative /PCR positive
(n = 5) was amplified using the specific Mycoplasma
primers of the RespoCheck Mycoplasma triplex real-
time PCR. DNA was sequenced by BaseClear (Leiden,
the Netherlands) by an automated DNA sequencer. The
nucleotide sequences were compared with GenBank
sequences using the Basic Local-Alignment Search
Tool(BLAST) of the NCBI-NIH for homology [26]. Pair-
wise sequence alignments were performed using the
Clustal algorithm implemented in the program DNA
star (DNASTAR Inc., Madison, WI).
Analyses of sensitivity and specificity
The analytical sensitivity of the RespoCheck triplex PCR
was determined by its ability to detect a low concentra-
tion of M. bovis, M. dispar and M. bovirhinis and there-
fore expressed as a concentration (ng/assay and cfu/mL)
[24]. The analytical specificity of the assay was calculated
for each target microorganism using the following defin-
ition for specificity as the percentage of true negative
samples/ the number of true negative samples and the
number of false positive samples [27].
Calculation of diagnostic sensitivity, specificity and
Cohen’s Kappa Coefficient was performed as described
[28]. We therefore used the results of the PCR/DGGE
analysis as reference standard.
Statistical analyses
Differences in PCR results were analysed for statistical
significance by the non-parametric Mann–Whitney U
test in the GraphPad Prism version 5.0 software, with
P < 0.05 considered significant.
Results
Analytical sensitivity and linear detection range of the
RespoCheck triplex
The linearity of quantification of the RespoCheck triplex
Mycoplasma real-time PCR was established through a
linear regression plot by plotting the Ct-values against
the values of log10 DNA concentration tested per reac-
tion. The M. dispar single and RespoCheck triplex real-
time PCR showed a linear detection range from 10 ng to
10 fg DNA per assay with a linear correlation (R2) value
of 0.999 (Table 3; Fig. 1.). The M. bovis and M. bovirhi-
nis single and RespoCheck real-time PCR showed a lin-
ear detection range from from 1 ng to 100 fg DNA per
assay, with a R2 value of 0.999 (Table 3; Fig. 1). In BALF
Table 3 Performance of the RespoCheck Mycoplasma real-time PCR in which the M. dispar, M. bovis and M. bovirhinis DNAs were
diluted in PBS (A) or cells were spiked in BALF (B)
A
PCR Agent Real time PCR
R2 Slope Efficiency (%) Linearity (ng) Detection limit (ng/assay)
Singleplex PCR M. dispar 0.9995 −3.3836 97.49 10 ng-10 fg 10 fg
M. bovis 0.9966 −3.1137 109.49 10 ng-10 fg 10 fg
M. bovirhinis 0.9955 −3.5033 92.95 10 ng-10 fg 10 fg
Triplex PCR M. dispar 0.9989 −3.1175 109.3 10 ng-10 fg 10 fg
M. bovis 0.9955 −3.6240 88.8 10 ng-100 fg 100 fg
M. bovirhinis 0.9939 −3.3735 97.9 10 ng-100 fg 100 fg
B
PCR Agent Real time PCR
R2 Slope Efficiency (%) Linearity (CFU/ml; log 10) Detection limit (CFU/assay)
Singleplex PCR M. dispar 0.995 3.248 ± 0.1276 103.2 6.5–2.5 1–2
M. bovis 0.995 3.453 ± 0.1178 94.8 6.5–1.5 0.5
M. bovirhinis 0.981 3.395 ± 0.2698 97.0 5.5–1.5 0.5
Triplex PCR M. dispar 1.000 3.534 ± 0.04608 91.9 6.5–2.5 1–2
M. bovis 0.993 3.462 ± 0.1440 94.5 6.5–1.5 0.5
M. bovirhinis 0.965 2.750 ± 0.3014 131.0 5.5–1.5 0.5
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spiked samples, the detection limit of the RespoCheck triplex
real-time PCR was 300 cfu/mL for M. dispar, and 30 cfu/mL
for M. bovis or M. bovirhinis (Table 3; Fig. 2). In the Respo-
Check Mycoplasma real-time PCR, 5 μL was tested and the
analytical sensitivity was therefore 1–15 cfu/assay. A good
linear correlation (R2 > 0.96) was found between the values
of BALF spiked samples and the Ct-values in the Respo-
Check Mycoplasma triplex or singleplex real-time PCR for
the three Mycoplasmas (Table 3).
Analytical specificity of the RespoCheck triplex PCR
RespoCheck Mycoplasma triplex PCR in silico BLAST
searchs (http://blast.ncbi.nlm.nih.gov/Blast.cgi) for the
specificity of the M. dispar amplicon revealed a 100%
identity (E-value 1E−46) for 2 hits for M. dispar complete
genome sequence. The in silico BLAST search for ampli-
con of M. bovis we found a 99–100% identity (E-values
4E−43 - 6E−45) to 31 complete genome or 16S ribosomal
partial sequence, and for the amplicon of M. bovirhinis
we found a 99–100% identity (E-values 5E−50 - 1E-51.)
For the M. bovirhinis amplicon a 97% identity (3E-40)
was found for 11 hits for Mycoplasma canis
(Taxid:29,555).
Seventeen Mycoplasma strains (Table 1) and 107 bacter-
ial strains (Table 2) were used to calculate the analytical
specificity of the RespoCheck Mycoplasma triplex PCR.
The RespoCheck Mycoplasma triplex real-time assay for
detecting M. bovis, M. dispar and M. bovirhinis possessed
an analytical specificity of 100% (0 FP), 98.2% (2 FP) and
99.1% (1 FP), respectively. No cross-reactivity in the Respo-
Check Mycoplasma triplex real-time assay was observed
with any of the 107 bacterial strains. The M. dispar PCR
did however cross-react with Acholeplasma axanthum
Fig. 1 Analytical sensitivity of M. bovis, M. dispar and M. bovirhinis in
single and RespoCheck triplex PCR assays. Ten-fold serial dilutions of
M. bovis, M. dispar and M. bovirhinis DNA were made in PBS in a
range from 1 ng down to 10 fg/assay. The resulting samples were
tested in the M. bovis, M. dispar and M. bovirhinis single and
RespoCheck triplex real-time PCR
Fig. 2 Analytical sensitivity of M. bovis, M. dispar and M. bovirhinis
single and RespoCheck triplex real-time PCR in spiked BALF samples.
Ten-fold serial dilutions of M. bovis, M. dispar and M. bovirhinis were
made in BALF samples in a range from 3 × 106 down to 0.3 cfu/mL.
The resulting samples were subjected to DNA isolation and testing
in the M. bovis, M. dispar and M. bovirhinis single and RespoCheck
triplex real-time PCR
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S743 and M. alkalescens PG 31/D 12. In silico se-
quence data analyses from the 16S V3 genomic DNA
region showed no similarity of M. dispar specific
sequences with the A. axanthum S743 and M. alka-
lescens PG 31/D 12 isolates. The M. bovirhinis Respo-
Check triplex PCR cross-reacted with M. canis with a
Ct-value of 20.4. In the M. bovis RespoCheck triplex
PCR we found a cross-reaction with M. agalactiae.
Based on the almost 100% similarity of M. canis
PG14 16S rRNA gene and the M. bovirhinis16S
rRNA, it is not possible to prevent for this cross-
reaction.
Diagnostic sensitivity and specificity of the RespoCheck
triplex compared with DGGE
To study the influence of centrifugation of the BALF
samples on the PCR results we compared the PCR
results from the BALF samples before and after cen-
trifugation (10 min at 4600×g). A significant lower
Ct-value (P < 0.05; non-parametric Wilcoxon statis-
tics) in the RespoCheck Mycoplasma triplex real-
time PCR was found for M. bovis and M. dispar in
the pellet of the centrifuged BALF samples. Several
M. bovis, M. bovirhinis and M. dispar mix-infections
could be detected in one BALF sample with a differ-
ence of 10 Ct-values between the three species and
were in accordance with the PCR/DGGE analysis
(Fig 3). Therefore we used the pellet of the centri-
fuged BALF samples (50× concentrated) to deter-
mine the presence of the three Mycoplasma species
in 44 BALF samples by real-time PCR.
The calculated diagnostic sensitivity and specificity
the RespoCheck triplex PCR is reported in Table 4.
As the diagnostic specificity is very low (0.1944,
0.739, 0.3889 for M. dispar, M. bovis and M. bovirhi-
nis respectively) we analysed the sequence of the pro-
duced amplicon of five DGGE negative /PCR positive
and five DGGE positive PCR positive samples. The
sequence of both products was confirmed as M.
bovis, M. dispar or M. bovirhinis, as all sequences
had a high E-value (3e-44) and 100% Query cover
(100%) against the homologue sequence using the
BLAST of the NCBI-NIH. Comparison of the Ct-
values of PCR positive/ DGGE negative and the PCR
positive/ DGGE positive samples with a non-
parametric Mann Whitney test, showed that the Ct
values of M. dispar and M. bovis were significantly
lower, p = 0.0026 and 0.0282, respectively. In the M.
bovis and M. dispar PCR, the difference in Ct value
between PCR positive/ DGGE positive and PCR posi-
tive/ DGGE negative samples is at least 3.2, which in-
dicates a factor of 10 difference in concentration of
M. bovis and M. dispar DNA between these two
groups (Fig. 4). As a consequence the diagnostic
Fig. 3 Ct-values obtained in the RespoCheck Mycoplasama triplex
real-time PCR on DNA samples derived from BALF samples from M.
bovis, M. dispar and M. bovirhinis infected calves. PCRs were performed
on three variants of BALF samples: without centrifugation (A),
supernatant after centrifugation (B) and sediment of after centrifugation
(50 times concentrated) (C)
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specificity of the RespoCheck triplex PCR is underva-
lued by this method. We compared the results of the
M. bovis, M. dispar and M. bovirhinis RespoCheck
triplex PCR with the results of the PCR/DGGE ana-
lysis. The detection limit of the M. bovis, M. dispar
and M. bovirhinis PCR/DGGE analysis was, as deter-
mined by APHA, 0.7 × 103 cfu/mL, 16 × 103 cfu/mL
and 0.5 × 103 cfu/mL, respectively (Fig. 5).
Discussion
PCR assays for the detection of Mycoplasmas gener-
ally target sequences on the 16S rRNA gene [29, 30].
In this study we used the highly conserved 16S rRNA
sequence to set up the RespoCheck Mycoplasma
triplex real-time PCR assay for the specific detection
of M. bovis, M. dispar and M. bovirhinis in BALF
samples of calves.
The lowest concentration of M. dispar which could be
detected with the RespoCheck triplex PCR assay is
around 300 cfu/mL. With a copy number of 16S rRNA
of one or two (https://rrndb.umms.med.umich.edu/) and
with a test volume of 5 μl the lowest concentration
which could be detected is around 1–2 cfu/assay. The
lowest concentration of M. bovis and M. bovirhinis
which could be detected with the RespoCheck triplex for
M. bovis, and M. bovirhinis is around 0.5 cfu/assay.
From the calculated analytical sensitivity of the M. bovis,
M dispar and M. bovirhinis RespoCheck triplex PCR
(0.5–2 cfu/assay) we conclude that the RespoCheck
triplex PCR has a good analytical sensitivity. It was
shown that the use of a pellet from 25 mL BALF after
centrifugation instead of not-centrifuged BALF samples
increased the analytical sensitivity of the RespoCheck
triplex PCR assay. In order to determine the analytical
specificity of the RespoCheck triplex PCR we analysed
the DNAs from panels of Mycoplasma and bacterial
strains. In the M. bovis RespoCheck Mycoplasma triplex
real-time PCR we found a cross-reaction with M. aga-
lactiae. Phylogenetic analyses on 16S rRNA sequences
and comparing the 16S rRNA sequences of M. bovis and
M. agalactiae [25] at NCBI (www.ncbi.nlm.nih.gov), we
found a close relationship between M. agalactiae and M.
bovis, with a 99% nucleotide identity between their 16S
rRNA sequences. However, M. bovis causes calf pneu-
monia, mastitis, and arthritis in cattle [16, 31], M. aga-
lactiae is the causal agent of contagious agalactia in
goats and sheep [32]. Although unusual, M. agalactiae
has been detected from cattle samples [33, 34]. There-
fore the cross reactivity for M. agalactiae might be a
problem for the intended BALF samples in the M. bovis
Table 4 Diagnostic sensitivity and specificity of the RespoCheck Mycoplasma triplex real-time PCR compared with the PCR/DGGE
method
M. dispar PCR + PCR - Total Diagnostic specificity and sensitivity
DGGE + 8 0 8 Sensitivity =1
DGGE - 29 7 36 Specificity =0.1944 (95% CI: 0.0819–0.3602)
Total 37 7 44
M. bovis PCR + PCR - Total Diagnostic specificity and sensitivity
DGGE + 20 1 21 Sensitivity =0.9524 (95% CI: 0.7618–0.9988)
DGGE - 6 17 23 Specificity =0.7391 (95% CI: 0.5159–0.8977)
Total 26 18 44
M. bovirhinis PCR + PCR - Total Diagnostic specificity and sensitivity
DGGE + 7 1 8 Sensitivity =0.8750 (95% CI: 0.4735–0.9968)
DGGE - 22 14 36 Specificity =0.3889 (95% CI: 0.2314–0.5654)
Total 29 15 44
Fig. 4 The Ct-level of DNA derived from BALF samples from M. bovis,
M. dispar and M. bovirhinis infected calves of PCR/DGGE analyses of
DGGE APHA negative and positive samples. Significant P values are
indicated by *
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PCR. In the M. bovirhinis RespoCheck triplex real-time
PCR one false positive reaction was obtained on DNA
from M. canis. M. canis can be isolated from the repro-
ductive tract of dogs, but has not been proved to cause
disease in dogs. However, it has been shown to cause
clinical signs of pneumonia in experimentally challenged
calves [35] and M. canis has been isolated from rumi-
nants in Britain [36, 37]. Depending on the incidence of
M. canis in ruminants, this may give false-positive
results in the M. bovirhinis RespoCheck triplex real-time
PCR. DNA samples from M. alkalescens and A.
axanthun showed high Ct-values (>35) for M. dispar in
the RespoCheck triplex real-time PCR, and were there-
fore classified as false-positive (Ct of 40 cycles or less
were considered to be positive). M. alkalescens and M.
bovigenitalium are important Mycoplasmas that can in-
fect cattle and cause mastitis, arthritis and respiratory
disease [17]. However, in the sequence analyses of the
PCR-positive and DGGE-negative M. dispar BALF sam-
ples, we did not find any indication for the presence of
M. alkascens, underlining the high specificity for M. dis-
par in the RespoCheck triplex real-time PCR.
Monitoring for Mycoplasma species in BALF samples
through collection and testing of BALF samples by cul-
ture is hampered by the fastidious nutritional require-
ments, lengthy culture of mycoplasmas, and their
susceptibility to growth inhibitors. As a consequence,
Mycoplasma culture is time-consuming, costly, and re-
quires specific expertise. Moreover, Mycoplasma species
may easily be overgrown by bacterial contaminants or by
more rapidly growing Mollicutes, notably Acholeplasmas.
The PCR/DGGE method of the APHA can differentiate
13 bovine Mycoplasma species [18] including the target
Mycoplasmas of the RespoCheck Mycoplasma triplex
real-time PCR and in contrary to the RespoCheck can dif-
ferentiate between M. bovis and M. canis. Additional the
PCR/DGGE is capable of detecting mixed cultures, which
would have been difficult to detect by culture methods
[18]. Therefore we used this method as a reference for
determining the diagnostic sensitivity and specificity of
the RespoCheck Mycoplasma triplex real-time PCR.
Possibly due to the lower sensitivity of the DGGE ana-
lysis compared to the RespoCheck triplex PCR (almost
factor 10) and its use as reference method to validate the
RespoCheck triplex PCR, the latter test method scores
29, 6 and 22 M. dispar, M. bovis and M. bovirhinis re-
spectively out of 44 more samples as false-positive and
therefore the diagnostic specificity of the RespoCheck
triplex PCR is underestimated. The transport and stor-
age conditions or differences in DNA preparation of par-
ticularly the more diluted BALF samples for the PCR/
DGGE method could have induced a lower sensitivity of
Fig. 5 DGGE fingerprinting profiles of 16S ribosomal DNA fragments obtained after amplification by PCR. Lane 1 contains the negative water control,
lanes 2 to 8 contain several Mycoplasma strains as reference (lane and strain designations indicated), lanes 9, 10 and 11 contain three 10-fold serial
dilutions of M. dispar (starting with 16 × 104 cfu/mL), lanes 12, 13 and 14 contain three 10-fold serial dilutions of M. bovis (starting with 7 × 103 cfu/mL)
and lanes 15, 16 and 17 contain three 10-fold serial dilution of M. bovirhinis (starting with 0.5 × 104 cfu/mL)
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the PCR/DGGE analysis. The Ct values of the M. bovis,
and M. dispar PCR positive and DGGE positive samples
are significant (P < 0.05 Mann Whitney test) lower than
the M. bovis, and M. dispar PCR positive DGGE negative
samples, which confirms the difference in the analytical
sensitivity between the RespoCheck triplex PCR and
DGGE analyse. In the M. bovis and M. dispar PCR, we
found a 10 fold difference in the Ct values between the
DGGE positive/ PCR positive and DGGE negative/ PCR
positive samples, which indicates a higher diagnostic sen-
sitivity of M. bovis and M. dispar PCR than the DGGE
analyses. Results by DGGE from BALF samples with
mixed infections could be reproduced by the triplex PCR,
suggesting that there is no significant PCR bias when the
triplex PCR is used for Mycoplasma detection in field
samples. The PCR has thus a higher analytical sensitivity
than the DGGE.
Conclusion
In conclusion, the RespoCheck Mycoplasma triplex PCR-
test appears to be a sensitive and specific test for the
detection of M. bovis, M. dispar and M. bovirhinis in
BALF samples of calves.
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